EHA2025レポート④ Late-breaking Session

成人ITPにおける新規抗CD38抗体の臨床的有用性 SAFETY AND EFFICACY OF CM313 IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Yanmei Xu（Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China）